Back to Investors

Bloomfield Capital Partners

Evidence PackPROIndependent
Real EstateINDIANAPOLIS, IN, US
AUM
$170M
Ownership
independent
Stakeability
41 / LOW
Priority
Tier
Employees
5

Bloomfield Capital Partners is an independent real estate investment firm specializing in commercial properties.

SEC RegisteredFund PerformanceBDC ExposureInstitutional HoldersTeam DataRegulatory

Coverage

50%

Adaptive profile: standard

Signals present
6/12
SEC / ADVFund Performance(50)BDC Exposure(6)13F Holders(15)Team(30)ILS Deals(0)Regulatory(25)Legal(0)Lobbying(0)Hiring(0)News(0)GP Stakes Deals(0)

Data Freshness

Recent Changes

Stakeability Breakdown

41 / 100
Fund PerformanceAUM growth and fundraising track record
58
Team StabilityLeadership continuity and key person risk
17
Market PositionBrand strength and competitive positioning
41
Succession ReadinessNext-gen leadership and governance structure
60
Transaction FeasibilityLikelihood of a stake transaction
29
Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
161504
SEC File Number
801-74187
Registration Type
Registered
Filing Date
Apr 9, 2025
Employee Count
N/A
Discretionary AUM
$125.2M
Private Funds
6
PE Funds
6
VC Funds
N/A
RE Funds
N/A
Hedge Funds
N/A
Gross Assets (Private)
$125.2M
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.